UK Government Health Agency Issued Final Guidelines Recommending Against Benlysta Coverage
Sunday, April 29, 2012
In its final draft guidance the United Kingdom’s health watchdog National Institute for Health and Clinical Excellence (NICE) continues to recommend against coverage by the National Health Service of the recently approved Benlysta (belimumab) for lupus despite a cost-saving offer from the manufacturers. Please visit http://www.thepetitionsite.com/1/cover-Benlysta/ to sign a petition calling for NICE to reconsider its position. Read more from the British newspaper The Guardian.
On the go?
Text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.
Message and Data Rates May Apply. Text STOP to 50555 to STOP. Text HELP to 50555 for HELP. Full Terms